MS: Busting the Myths
May 24, 2022 | Research
ABX-002, an experimental treatment for multiple sclerosis (MS) being developed by Autobahn Therapeutics, promoted the restoration of the myelin sheath in preclinical models of the disease, new data show. The research, which specifically tested an analog of ABX-002 called LL-341070, will be presented […]
May 10, 2022 | Funding, Research, Study, Training
MSNZ is delighted with the announcement from the New Zealand MS Research Trust that they have received funding of NZ$150,000 a year for three years to support neurologists who wish to travel overseas to specialise in the treatment of people […]
May 3, 2022 | Advocacy, Research, Study, Treatments
New Zealand Neurologists are undertaking a survey of people who have travelled overseas to have a bone marrow (stem cell / aHSCT) transplant for multiple sclerosis. The study involves answering a questionnaire and giving consent for doctors to access your […]
February 15, 2022 | Event, Grants, Life with MS, MS Voice, Newsletter, Research, Study, Support
Keep up to date with what we have been working on, tips to live well with MS and much more. Read the latest newsletter from MSNZ: MS Voice Newsletter February 2022 To receive the newsletter directly into your inbox each […]
February 9, 2022 | Education, Research, Study, Treatments
New Zealand Neurologists are undertaking a survey of people who have travelled overseas to have a bone marrow (stem cell) transplant for multiple sclerosis. The study involves answering a questionnaire and giving consent for doctors to access your medical records. […]